Trademark Overview

---

On Friday, March 24, 2000, a trademark application was filed for OPTANZA with the United States Patent and Trademark Office. The USPTO has given the OPTANZA trademark a serial number of 76008986. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 1, 2012. This trademark is owned by AstraZeneca AB. The OPTANZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of diseases and disorders of the central nervous system, the peripheral nervous system and urological system; pharmaceutical preparations and substances for pain control and anaesthesia

General Information

---

Serial Number	76008986
Word Mark	OPTANZA
Filing Date	Friday, March 24, 2000
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, June 1, 2012
Registration Number	3008109
Registration Date	Tuesday, October 25, 2005
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, August 2, 2005

Trademark Statements

---

Goods and Services

Pharmaceutical preparations and substances for use in the treatment of diseases and disorders of the central nervous system, the peripheral nervous system and urological system; pharmaceutical preparations and substances for pain control and anaesthesia

Classification Information

---

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, June 1, 2012
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

---

Party Name	AstraZeneca AB
Party Type	30 - Original Registrant
Legal Entity Type	16 - Limited Liability Company
Address	Sodertalje SE

---

Party Name	AstraZeneca AB
Party Type	20 - Owner at Publication
Legal Entity Type	16 - Limited Liability Company
Address	Sodertalje SE

---

Party Name	AstraZeneca AB
Party Type	10 - Original Applicant
Legal Entity Type	16 - Limited Liability Company
Address	Sodertalje SE

Trademark Events

---

Event Date	Event Description
Friday, June 1, 2012	CANCELLED SEC. 8 (6-YR)
Tuesday, July 24, 2007	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 24, 2007	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 25, 2005	REGISTERED-PRINCIPAL REGISTER
Tuesday, August 2, 2005	PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2005	NOTICE OF PUBLICATION
Thursday, June 9, 2005	ASSIGNED TO EXAMINER
Friday, May 20, 2005	AMENDMENT FROM APPLICANT ENTERED
Thursday, September 23, 2004	CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 20, 2005	ASSIGNED TO LIE
Wednesday, May 18, 2005	1(B) BASIS DELETED; NEW BASIS REQUESTED
Saturday, October 30, 2004	NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 4, 2005	PETITION TO DIRECTOR - GRANTED
Thursday, September 23, 2004	PETITION TO DIRECTOR RECEIVED
Thursday, September 23, 2004	PAPER RECEIVED
Monday, May 10, 2004	EXTENSION 5 GRANTED
Friday, April 30, 2004	EXTENSION 5 FILED
Thursday, May 6, 2004	CASE FILE IN TICRS
Friday, April 30, 2004	TEAS EXTENSION RECEIVED
Monday, November 10, 2003	EXTENSION 4 GRANTED
Thursday, October 30, 2003	EXTENSION 4 FILED
Thursday, October 30, 2003	TEAS EXTENSION RECEIVED
Thursday, May 15, 2003	EXTENSION 3 GRANTED
Tuesday, April 22, 2003	EXTENSION 3 FILED
Wednesday, April 2, 2003	PAPER RECEIVED
Monday, January 13, 2003	EXTENSION 2 GRANTED
Tuesday, October 29, 2002	EXTENSION 2 FILED
Wednesday, October 30, 2002	PAPER RECEIVED
Friday, April 12, 2002	EXTENSION 1 GRANTED
Wednesday, March 27, 2002	EXTENSION 1 FILED
Wednesday, March 27, 2002	PAPER RECEIVED
Tuesday, October 30, 2001	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 7, 2001	PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2001	NOTICE OF PUBLICATION
Thursday, February 22, 2001	APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 15, 2000	CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 11, 2000	NON-FINAL ACTION MAILED

Related Keywords

---

optanza system nervous substances preparations pharmaceutical control anaesthesia urological pain central